Best Leukemia doctors in Barcelona: TOP 4 doctors

• Dr. Susana Rives Sola specializes in leukemia treatment and bone marrow transplantation for children.
• Utilizes chemotherapy, radiation therapy, targeted therapy, immunotherapy, and stem cell transplant.
• Has experience practicing at medical institutions in Spain, the United States, and Germany.
• Member of the European Society for Blood and Marrow Transplantation (EBMT).
• Speaks Spanish, English, and German fluently.

• Dr. Jaume Mora Graupera specializes in leukemia treatment in pediatric patients.
• Standard treatment options include chemotherapy, targeted therapy, immunotherapy, and stem cell transplant.
• International training at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in the USA.
• Member of the International Society of Pediatric Oncology (SIOP) and the American Society of Clinical Oncology.
• Heads the Hematology Oncology Department at Sant Joan De Déu — Barcelona Children’s Hospital.

Dr. Francesc Cobo Valien graduated from the Faculty of Medicine of the University of Barcelona in 1990.

He received his specialization in oncohematology at the Hospital Clínic de Barcelona in 1995. He combined medical practice and research activities in the period 1996-2002.

He received his Doctor of Medicine degree from the University of Barcelona in 2002.

Dr. Kobo continues his research and has been awarded grants:

•Interdepartmental Commission for Innovation of the Generalitat de Catalunya

•Scholarship Fund Universitaria Agustí Pedro i Pons

•Farreras Valentí & Schering Plough School of Hematology Scholarship

•Award for the best report at the Council of the Spanish Hematology Association

•Grant from the Catalan Society of Hematology

Specialization:

•Lymphoma

•Acute leukemia

•Chronic leukemia

•Autoimmune pancytopenia

Dr. Francesc Bosch is an expert in Chronic Lymphocytic Leukemia (CLL) and lymphomas. He leads research in the molecular causes and new treatments for CLL and other lymphoproliferative disorders.

He has published over 100 articles in leading journals, including The New England Journal of Medicine and Nature Medicine. Dr. Bosch oversees more than 80 clinical studies, from phase 1 to phase 3, and plays a key role in developing new drugs.

He is the Head of Hematology at Vall d’Hebron University Hospital and IOB Institute of Oncology. He also serves as president of GELLC and is a professor of hematology. His work has improved diagnosis and treatment for blood diseases.